SCHEMBL3601148

SCHEMBL3601148

O=C(O)CCCCC(O)/C=C/c1ccccc1OCc1ccc(C2CCCCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 11/20 0.44
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTGER1 P34995 1/20 0.41
PTGER4 P35408 1/20 0.41
PTGER3 P43115 1/20 0.41
PTGER2 P43116 1/20 0.41
CSF1R P07333 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CDK4 P11802 1/20 0.39
CCNB1 P14635 1/20 0.39
CCND1 P24385 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
SGMS2 Q8NHU3 1/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3601150 1.00 FFAR4 (0.44) FFAR4CYP3A4TSHRHSD17B10PTGER1
SCHEMBL6138566 0.90 PPARG (0.41) PTGER1PTGER4PTGER3PTGER2CSF1R
SCHEMBL13443300 0.86 KMT2A (0.42) FFAR4CYP3A4TSHRHSD17B10PTGER1
SCHEMBL3590630 0.85 PTGER1 (0.48) FFAR4CYP3A4TSHRHSD17B10PTGER1
SCHEMBL3590625 0.85 PTGER1 (0.48) FFAR4CYP3A4TSHRHSD17B10PTGER1
SCHEMBL3590675 0.79 FFAR4 (0.47) FFAR4CYP3A4TSHRHSD17B10PTGER1
SCHEMBL13443265 0.76 HPGD (0.36) CYP3A4TSHRHSD17B10CSF1RPOLB
SCHEMBL6138624 0.76 PTGER4 (0.43) FFAR4PTGER1PTGER4PTGER3PTGER2
SCHEMBL6280253 0.74 MAPT (0.52) PTGER4
SCHEMBL6280250 0.74 MAPT (0.52) PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674825-B2 Dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2010-03-09 US disclosed
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties BAYER AKTIENGESELLSCHAFT 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058314-A1 Novel dicarboxylic acid derivatives with pharmaceutical properties PC, GOT2, SDHA FFAR4 368/4885CYP3A4 349/4885TSHR 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.